Near-Infrared Fluorescence Imaging and Photothermal Therapy of Tumors Using a Targeted Helical Protein Scaffold
ACS Applied Bio Materials · 2026
DOI: 10.1021/acsabm.6c00903 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2026. Verfasst von Nicole Carrillo-Malani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania19104, United States. Hauptthemen laut MEDLINE: Photothermal Therapy, Optical Imaging, Biocompatible Materials, Antineoplastic Agents. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NIBIB NIH HHS, Health Research Formula Fund from the Pennsylvania Department of Health.
Abstract (Originalsprache)
Photothermal therapy (PTT) using near-infrared (NIR) photoactive agents offers a minimally invasive approach for tumor ablation; however, many existing platforms rely on polymeric or nanoparticle carriers that limit targeting precision and control over dye loading. Here, we report the design of a modular eight-helix protein scaffold containing 20 cysteine residues that enables covalent, site-specific conjugation of the NIR dye AQuora800-maleimide. The protein scaffold is expressed with different HER2-targeting ligands, and in vitro screening identifies an affibody dimer-based construct (AD-20AQ) as the most effective platform for targeted fluorescent imaging and therapy. In vivo pharmacokinetic imaging studies in a 4T1 murine tumor model reveal enhanced tumor accumulation of AD-20AQ compared to a monolabeled affibody dimer (AD-1AQ), with sustained retention in HER2-positive tumors. Furthermore, PTT of HER2 tumors with an 808 nm laser, following intravenous administration of AD-20AQ, leads to complete tumor ablation. Collectively, these results establish targeted, labeled protein scaffolds as a versatile platform for NIR fluorescence imaging and photothermal therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania19104, United States.
- Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania19104, United States.
ORCID-Profile: Zhiliang Cheng, Andrew Tsourkas
Förderung
- NIAMS NIH HHS
- NIBIB NIH HHS
- Health Research Formula Fund from the Pennsylvania Department of Health
- University of Pennsylvania Accelerating Lab to Market Pre-Seed Grant
- National Institutes of Health (NIH)
- Institute of Translational Medicine and Therapeutics (ITMAT)
- Translational Biomedical Imaging Center Collaborative Pilot Grant Program (TBIC)
Zitieren
APA
Carrillo-Malani, N., Ho, G., Liang, Q., Miller, J., Busch, T. M., Amirshaghaghi, A., Cheng, Z., & Tsourkas, A. (2026). Near-Infrared Fluorescence Imaging and Photothermal Therapy of Tumors Using a Targeted Helical Protein Scaffold. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.6c00903
Vancouver
Carrillo-Malani N, Ho G, Liang Q, Miller J, Busch TM, Amirshaghaghi A, et al. Near-Infrared Fluorescence Imaging and Photothermal Therapy of Tumors Using a Targeted Helical Protein Scaffold. ACS Applied Bio Materials. 2026. doi:10.1021/acsabm.6c00903
BibTeX
@article{CarrilloMalani2026,
author = {Carrillo-Malani, Nicole and Ho, Gabrielle and Liang, Qiushi and Miller, Joann and Busch, Theresa M and Amirshaghaghi, Ahmad and Cheng, Zhiliang and Tsourkas, Andrew},
title = {Near-Infrared Fluorescence Imaging and Photothermal Therapy of Tumors Using a Targeted Helical Protein Scaffold},
journal = {ACS Applied Bio Materials},
year = {2026},
doi = {10.1021/acsabm.6c00903}
}
EUVIMED